Featured Research

from universities, journals, and other organizations

UCSB Lab Discovers Cross-Protective Vaccine

Date:
December 6, 2001
Source:
University Of California - Santa Barbara
Summary:
New medical research at the University of California, Santa Barbara represents a significant step toward preventing infections through the development of vaccines that elicit protection against several different disease-causing strains.

(Santa Barbara, Calif.) – New medical research at the University of California, Santa Barbara represents a significant step toward preventing infections through the development of vaccines that elicit protection against several different disease-causing strains. The work, by UCSB biologists Douglas M. Heithoff, Steve Julio, David A. Low, Robert L. Sinsheimer, and Michael J. Mahan, is an extension of earlier breakthrough research in which a strain of Salmonella was forced, through a new DNA technology, to "show its hand," thus allowing the organism to defend against it. The technology used in this vaccine is called DNA adenine methylase, or "Dam," and was discovered by Mahan’s team in 1999.

Related Articles


The new developments are described in articles in the November and December issues of the journal Infection and Immunity. "One of the main obstacles of vaccine development is that there are often many strains that can cause disease in individuals vaccinated against a single strain or a small set of strains," said Mahan. "This is the principle reason why different flu vaccines need to be administered every year, and why disease can occur in vaccinated individuals. This obstacle is a big problem for Salmonella, which has more than 2500 pathogenic strains. Using Dam technology, we have developed a Salmonella vaccine that is cross-protective to different salmonella strains."

He said that the development of cross-protective vaccines is paramount to the defense against biowarfare agents wherein pathogenic strains may have been "weaponized" by selecting for strains that overcome the immunity in vaccinated individuals. In effect, this renders many of our current vaccines obsolete.

In the December issue of Infection and Immunity, Mahan explains that "We have expanded the use of Dam technology to Yersinia pseudotuberculosis which is a very close cousin of the human plague-causing organism, Yersinia pestis. Dam mutants of Yersinia are completely disabled in their ability to cause disease. Immunized with these Dam mutants fully protects against Yersinia infection – in other words these immunized mice can’t be killed by virulent Yersinia."

Mahan noted that his research team is now exploring whether the Salmonella Dam technology can be used to induce immunity to other bacterial and viral pathogens. This work has been recently funded by a University of California BioSTAR biotechnology grant of $1 million. (BioSTAR -- Biotechnology Strategic Targets for Alliances in Research -- is a University of California-wide biotechnology matching grants program that forges partnerships among businesses, UC scientists, engineers and students.)

The UCSB research team has formed the company Remedyne, a private biotechnology company focused on developing potent immune stimulating vaccines and antimicrobial agents to treat infectious diseases in humans, companion animals and livestock. The University of California owns the patent for the Dam technology which is licensed to Remedyne. In human health research, the company is focusing on technology to combat cancer, infections of the ear, respiratory and urinary tract.


Story Source:

The above story is based on materials provided by University Of California - Santa Barbara. Note: Materials may be edited for content and length.


Cite This Page:

University Of California - Santa Barbara. "UCSB Lab Discovers Cross-Protective Vaccine." ScienceDaily. ScienceDaily, 6 December 2001. <www.sciencedaily.com/releases/2001/12/011206073031.htm>.
University Of California - Santa Barbara. (2001, December 6). UCSB Lab Discovers Cross-Protective Vaccine. ScienceDaily. Retrieved November 26, 2014 from www.sciencedaily.com/releases/2001/12/011206073031.htm
University Of California - Santa Barbara. "UCSB Lab Discovers Cross-Protective Vaccine." ScienceDaily. www.sciencedaily.com/releases/2001/12/011206073031.htm (accessed November 26, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, November 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins